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Utah State Signs 2-Year
Research Deal with Korean
Bio Medical Institute |
Biological Engineering
05/20/2015
May 20, 2015 – It was a meeting of East and West on
Wednesday morning at the Innovation Campus where a
new deal was signed by USU researchers that could help
bring fresh answers in the fight against cancer, diabetes
and other diseases.
Representatives from the university and Department
of Biological Engineering signed an official research
agreement with SORAM Bio-Medicine Research Institute
of Seoul, South Korea. The research agreement ultimately
aims to improve combined radiotherapy and chemotherapy
cancer treatments through the use of naturally-occurring
compounds found in ginseng.
USU VP for Research and Dean of Graduate Studies Mark
McLellan, left, and Rob Behunin, VP for Advancement
and Commercialization, middle, sign a two-year research
agreement with Dr. Wonjun Cho, Director of the Soram
Bio-Medicine Institute.
USTAR-endowed professor of biological engineering
Foster Agblevor is the chief researcher behind the project.
Agblevor and his associates at SORAM plan to explore
the health-promoting benefits of Korean ginseng and other
ginseng species that have been used for centuries in
traditional Chinese and Korean medicine.
“The most active ingredients in these extractions are
ginsenosides which have been reported to have several
curative properties for diseases including type II diabetes,
erectile dysfunction and some cancerous tumors,”
he writes in a proposal. “There is intense interest in
investigating the properties of these extracts for non-
traditional medicinal applications. There have also been
attempts to develop ginseng hairy roots for ginsenoside
applications.”
College of Engineering Dean Christine Hailey and USTAR
Professor Foster Agblevor speak to a Korean delegation
about a new research agreement at USU.
Agblevor and his team at the BioEnergy Center at the USU
Innovation Campus will extract Korean red ginseng using
benign solvents and characterize the properties of the
extractives. They also plan to cultivate ginseng hairy roots
that will be extracted and characterized. The properties
of the two extracts will be compared and evaluated in
combined radiotherapy and chemotherapy treatments in
clinical trials at the SORAM Bio-Medicine Institute.
The research effort will initially be a two-year, $250,000
project.
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